Cardiac sclerod

50 %
50 %
Information about Cardiac sclerod
Health & Medicine

Published on March 11, 2014

Author: maushard



Presentation by Dr. Jonathan R. Lindner MD at the 13th Annual Cheri Woo Scleroderma Education Seminar on March 8, 2014 in Portland, Oregon. The seminar is a free public service hosted by the Oregon Chapter of the Scleroderma Foundation.

Cardiovascular Manifestations Systemic Sclerosis Jonathan R Lindner, MD M Lowell Edwards Professor of Cardiology Knight Cardiovascular Institute Oregon Health and Sciences University

Pathophysiology of SSc Inflammation Thrombosis Vasoconstriction Vessel wall hyperplasia Tissue injury and fibrosis Hypoxia

Cardiovascular Manifestations of SSc Valve disease? Pericardial disease Cor Pulmonale Myocarditis/ Cardiomyopathy Hypertrophy Conduction abnormalities Microvascular disease

Cardiac Complications: Scope of the Problem • Cardiac symptoms often go unnoticed • Symptoms attributed to lung or musculoskeletal disease • Recognized primary cardiac involvement in 20- 25% of those with diffuse SSc (much higher on autopsy series) • Presence of cardiac involvement is a poor prognostic feature and usually occurs in those with more advanced disease

Pulmonary Hypertension in SSc • High blood pressure in the lung arterial circulation. • Severe pulmonary hypertension affects 10- 12% of patients with SSc • Mortality 50% within 3 yrs • Most of the mortality is directly related to effects on the right ventricle • In those with long term survival there is considerable morbidity from the effects on the right ventricle

Koch ET, et al. Br J Rheumatol 1996;35:989 PAH and Survival in SSc

Right Heart Failure in SSc PAH • For any given increase in pulmonary pressure, the deleterious effect on the right heart is greater in SSc than in other diseases of PAH

Right Heart Failure in SSc PAH Right Heart FailureNormal

Secondary Tricuspid Regurgitation

Right Heart Failure: Symptoms and Complications • Fatigue, shortness of breath, exercise intolerance • Severe edema (swelling of legs, abdomen) • Liver dysfunction and cirrhosis • Gastrointestinal symptoms of bowel edema • Heart rhythm disorders (atrial fibrillation, ventricular tachycardia)

Risk Factors for PAH and Right Heart Failure • Late age of onset of SSc • Pre-existing lung disease, smoking • Raynaud’s • Certain antibodies (anti-U3RNP) • More severe SSc

How to Diagnose PAH

Treatment Options Pulmonary vasodilators: • Prostacyclin agonists • Phosphodiesterase-E5 inhibitors • Endothelin antagonists • Calcium channel blockers Immunosuppressive therapy Diuretics Oxygen Digoxin Lung transplantation Experimental: Ivadrabine, Tyrosine kinase inhibitors

Left Ventricular Dysfunction in SSc  Causes: - Heart inflammation/fibrosis - Small vessel dysfunction - “Raynaud’s” of the heart vessels  Occurs in approximately 5% of patients with SSc  Higher incidence with advanced age, hypertension, kidney disease, pulmonary disease, digital ulcers

Left Ventricular Dysfunction Normal Dysfunction

Myocyte Damage from Microvascular Disease

Myositis and Vasculitis Histology DE-Gd-MRI

Symptoms of LV Dysfunction • Shortness of breath • Fatigue, weakness • Cough, frothy sputum • Inability to sleep flat Symptoms of Coronary Vasospasm • Chest pain, acute shortneess of breath Symptoms of Myositis • Chest pain, fever, fatigue

Occult LV Dysfunction: Common First Manifestations • Stroke • Heart rhythm disturbance (atrial fibrillation, ventricular fibrillation) • Complications of poor blood flow (kidney dysfunction, confusion)

Diagnosis • Clinical suspicion • Echocardiogram • Once LV dysfunction is found, there is a workup for causes not related to SSc • Evaluation for myocarditis and microvascular dysfunction

RNI Detection of Perfusion Defects Stress Rest

MCE Evaluation of the Microcirculation

Treatment • Diuretics • ACE-inhibitors; Angiotensin receptor blocking agents • Beta blockers??? • If vasospasm suspected: calcium channel blocking vasodilators or long- acting nitroglycerine • ICD • Cardiac rehabilitation • If myositis: immunosupppressive therapy

Diastolic Heart Failure • No problem with the heart squeeze • Problem exists with the relaxation of the heart between squeezes • Due to fibrosis and enlarged heart cells that occurs with inflammation, early microvascular disease, renal disease, and hypertension

Diastolic Heart Failure

Pericarditis Sharp chest pain Positional pain Respiratory variation Fevers Shortness of breath Palpitations Symptoms

Pericarditis in SSc  Symptomatic pericarditis in 5-12%  Detected by imaging/autopsy in 33-70%  Common in limited scleroderma (CREST)  More common if there is PAH  Treatment with NSAIDs and/or steroids  Complications of disease: • Effusions (tamponade) • Constriction

Pericardial Effusion

Pericardial Effusion  Symptoms: chest pain, shortness of breath, dizziness, fatigue, swelling  When severe  cardiac collapse (tamponade)  Hemodynamically significant effusion in 10% of those with pericarditis  Can also be associated with renal disease

Pericardial Effusion: Detection 1. Clinical suspicion 2. Physical exam 3. Imaging

Pericardial Constriction • Encasement of the heart • Symptoms: fatigue, chest pain, swelling • Abdominal distention • Atrial fibrillation

Pericardial Constriction

Treatment for Complications • Drain fluid if it is causing more than mild symptoms or endangering heart function • For constriction, diuretics to unload the heart • Consider immunosuppressive therapy for constriction or refractory/recurrent effusion

What Does This Mean for You? 1. Awareness that there are cardiac manifestations in SSc is the first and most important step to discovering cardiovascular disease 2. Echocardiography is a common diagnostic test – it is generally part of the routine screening for pulmonary hypertension 3. More severe disease should lead to more frequent screening 4. Do not discount symptoms of shortness of breath, extreme fatigue, dizziness, chest pain 5. Aggressive treatment of hypertension 6. Other risk factor modification (exercise, smoking cessation, diet)

Add a comment

Related presentations

Related pages

Systemic scleroderma - Wikipedia, the free encyclopedia

Systemic scleroderma is a rare disease with an annual incidence of 1 to 2 per 100,000 individuals in the United States. The interval of peak onset ...
Read more

Scleroderma - Wikipedia, the free encyclopedia

Scleroderma, also known as systemic sclerosis, is a chronic systemic autoimmune disease characterised by hardening (sclero) of the skin (derma).
Read more

Scleroderma Symptoms Prognosis & Treatment

Read about scleroderma symptoms, treatment, prognosis, CREST, research, and more. Scleroderma is an autoimmune disease that affects the connective tissue.
Read more

Scleroderma | University of Maryland Medical Center

Scleroderma Description. An in-depth report on the causes, diagnosis, and treatment of scleroderma. Alternative Names. Systemic sclerosis; Localized ...
Read more

Scleroderma - Mayo Clinic

Scleroderma — Comprehensive overview covers symptoms and treatment of disorders that involve skin hardening.
Read more

Scleroderma: An Overview

What is scleroderma? Scleroderma is a chronic, although rare, autoimmune disease in which normal tissue is replaced with dense, thick fibrous tissue.
Read more

Scleroderma - Arthritis and Joint Conditions -

Scleroderma (systemic sclerosis) is both a rheumatic disease and a connective tissue disease.
Read more

systemic scleroderma - Genetics Home Reference

Systemic scleroderma is an autoimmune disorder that affects the skin and internal organs. Autoimmune disorders occur when the immune system malfunctions ...
Read more